KIORA PHARMACEUTICALS, INC. Accumulated Other Comprehensive Income
KIORA PHARMACEUTICALS, INC. (KPRX) had Accumulated Other Comprehensive Income of -$255.80 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-07
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$255.80K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$228.80K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$246.14K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$243.71K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$255.80K 10-Q · filed 2026-08-07 |
| 2026-03-31 | -$228.80K 10-Q · filed 2026-05-08 |
| 2025-12-31 | -$246.14K 10-Q · filed 2026-08-07 |
| 2025-09-30 | -$243.71K 10-Q · filed 2025-11-07 |
| 2025-06-30 | -$245.77K 10-Q · filed 2025-08-08 |
| 2025-03-31 | -$297.19K 10-Q · filed 2025-05-09 |
| 2024-12-31 | -$282.16K 10-K · filed 2026-03-25 |
| 2024-09-30 | -$75.21K 10-Q · filed 2024-11-08 |
| 2024-06-30 | -$245.74K 10-Q · filed 2024-08-09 |
| 2024-03-31 | -$264.37K 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$182.80K 10-K · filed 2025-03-25 |
| 2023-09-30 | -$266.17K 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$225.86K 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$215.41K 10-Q · filed 2023-05-09 |
| 2022-12-31 | -$182.74K 10-K · filed 2024-03-25 |
| 2022-09-30 | -$263.40K 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$224.86K 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$58.59K 10-Q · filed 2022-07-08 |
| 2021-12-31 | -$86.43K 10-K · filed 2023-03-23 |
| 2021-09-30 | -$59.87K 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$15.14K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $9.67K 10-Q · filed 2021-05-12 |
| 2020-12-31 | -$802.00 10-K/A · filed 2022-07-07 |
| 2020-09-30 | $122.52K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $139.63K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $139.65K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $139.47K 10-K · filed 2021-03-25 |
| 2019-09-30 | $137.93K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $135.19K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $133.83K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $134.33K 10-K · filed 2020-03-04 |
| 2018-09-30 | $137.09K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $130.71K 10-Q · filed 2018-08-03 |
| 2018-03-31 | $128.71K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $127.47K 10-K · filed 2019-03-01 |
| 2017-09-30 | $126.38K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $123.11K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $120.25K 10-Q · filed 2017-05-05 |
| 2016-12-31 | $120.19K 10-K · filed 2018-03-02 |
| 2016-09-30 | $114.44K 10-Q · filed 2016-11-01 |
| 2016-06-30 | $113.73K 10-Q · filed 2016-08-10 |
| 2016-03-31 | $114.22K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $114.79K 10-K · filed 2017-02-23 |
| 2015-09-30 | $103.33K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $104.89K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $74.90K 10-Q · filed 2015-05-18 |
| 2014-12-31 | $56.54K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |